CG Oncology (CGON) Receivables (2023 - 2026)
CG Oncology (CGON) posted Receivables of $1.3 million for Q1 2026, up 85.32% on a QoQ basis from $688000.0 in Q4 2025, and up 269.57% year-over-year from $345000.0 in Q1 2025.
CG Oncology (CGON) Receivables (2023 - 2026) Analysis & Trends
CG Oncology's Receivables history runs 4 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- Quarterly Receivables rose 269.57% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 269.57% YoY) and the FY2025 annual result came in at $688000.0, changed N/A from the prior year.
- Receivables was $1.3 million for Q1 2026 at CG Oncology, up from $688000.0 in the prior quarter.
- Across five years, Receivables topped out at $1.3 million in Q1 2026 and bottomed at $92000.0 in Q4 2023.
- A 4-year average of $438777.8 and a median of $345000.0 in 2025 frame the typical range for Receivables.
- Peak annual rise in Receivables reached 275.91% in 2025, while the deepest fall reached 125.49% in 2025.
- CG Oncology's Receivables stood at $92000.0 in 2023, then soared by 48.91% to $137000.0 in 2024, then jumped by 402.19% to $688000.0 in 2025, then soared by 85.32% to $1.3 million in 2026.
- Business Quant data shows CGON's Receivables at $1.3 million in Q1 2026, $688000.0 in Q4 2025, and $515000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CG Oncology | 6.01 Bn | 6.01 Bn | -1.88 Mn | 1.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.28 Mn |
| Dec 31, 2025 | 688,000.00 |
| Sep 30, 2025 | 515,000.00 |
| Jun 30, 2025 | 562,000.00 |
| Mar 31, 2025 | 345,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Mar 31, 2024 | 153,000.00 |
| Dec 31, 2023 | 92,000.00 |